Dr. Michael Fawzy, MD, MSc, MBBCh, MRCP(UK), MRCP(Neph) - Basildon university hospital  - Renal Consultant

Dr. Michael Fawzy

MD, MSc, MBBCh, MRCP(UK), MRCP(Neph)

Basildon university hospital

Renal Consultant

Basildon, Essex | United Kingdom

Main Specialties: Nephrology

Additional Specialties: Renal

ORCID logohttps://orcid.org/0000-0002-9769-1957


Top Author

Dr. Michael Fawzy, MD, MSc, MBBCh, MRCP(UK), MRCP(Neph) - Basildon university hospital  - Renal Consultant

Dr. Michael Fawzy

MD, MSc, MBBCh, MRCP(UK), MRCP(Neph)

Introduction

Michael T Fawzy, MD, MSc, MRCP(UK), MRCP(Neph), is a graduate of Minia University Medical School(Egypt). He is dually trained in internal medicine and nephrology . He has fulfilled his training program in 3 countries ie; The UK, Egypt and Saudi Arabia. Fawzy has been practicing since 2001, the last 3 years in London, UK, at Guy’s hospital (selected as one of the top 5 hospitals in the UK). Fawzy’s practice specializes in the care of renal failure in critically ill patients , Chronic kidney disease , Hypertension and Vasculitis. His special interests also include end-of-life issues, advanced directives, and furthering organ procurement. Fawzy is also a clinical associate lecturer of medicine at University Medical School in Egypt and is a member of Royal College of Physicians in London. He used to be lecturer and examiner at King’s college medical school in London. Fawzy has recently appointed as renal and general medicine consultant at Basildon university hospital in the UK. He is leading transition of chronic kidney disease in MSB(Mid Essex, Southend and Basildon) hospitals Trusts. He has received Distinguished Award from the Kuwaiti Society of Hypertension (an international society comprised of nephrologists and internists) for his research in recent advances of resistant hypertension treatment . He has received best quality improvement program award in Gulf area from international joint commission(JCI) .

Primary Affiliation: Basildon university hospital - Basildon, Essex , United Kingdom

Specialties:

Additional Specialties:

Research Interests:

Education

Aug 2018
MD (Neph)
-
-
Mar 2016
MRCP(Neph)
-
-

Experience

Dec 2018
EMPA
investigator
Nov 2018
CONVINCE
investigator

Publications

8Publications

133Reads

288Profile Views

1PubMed Central Citations

Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats.

Life Sci 2019 Jan 16;216:207-214. Epub 2018 Nov 16.

Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00243205183074
Publisher Site
http://dx.doi.org/10.1016/j.lfs.2018.11.031DOI Listing
January 2019
11 Reads
2.702 Impact Factor

A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: Application to a pharmacokinetic study in healthy volunteers.

J Pharm Biomed Anal 2019 Jan 1;163:153-161. Epub 2018 Oct 1.

Pharmaceutical Medicinal Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07317085183131
Publisher Site
http://dx.doi.org/10.1016/j.jpba.2018.09.052DOI Listing
January 2019
4 Reads
2.979 Impact Factor

Different resolution techniques for management of overlapped spectra: Application for the determination of novel co-formulated hypoglycemic drugs in their combined pharmaceutical dosage form.

Spectrochim Acta A Mol Biomol Spectrosc 2018 Dec 20;205:235-242. Epub 2018 Jun 20.

Pharmaceutical Medicinal Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.saa.2018.06.072DOI Listing
December 2018
2 Reads
2.353 Impact Factor

Acute kidney injury and critical limb ischaemia associated with the use of the so called "legal high" 3-fluorophenmetrazine.

CEN Case Rep 2017 Nov 15;6(2):152-155. Epub 2017 Jul 15.

Department of Renal Medicine, Kent and Canterbury Hospital, East Kent Hospitals University NHS Foundation Trust, Ethelbert Road, Canterbury, Kent, CT1 3NG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13730-017-0263-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694401PMC
November 2017
99 Reads

Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.

Asian Pac J Cancer Prev 2015 ;16(3):959-63

Departments of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Kingdom of Saudi Arabia E-mail :

View Article

Download full-text PDF

Source
December 2015
1 Read
1.500 Impact Factor

A survey on herbal management of hepatocellular carcinoma.

World J Hepatol 2011 Jul;3(7):175-83

Nabil Mohie Abdel-Hamid, Maiiada Hasan Nazmy, Ahmed Wahid Mahmoud, Michael Atef Fawzy, Marco Youssof, Biochemistry Department, Unit of Liver cancer research, Faulty of Pharmacy, Minia University, Minia 002086, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4254/wjh.v3.i7.175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158906PMC
July 2011
1 Read